Berghuijs, Karely M. van Thiel
Kaddas, Heydon K.
Trujillo, Gillian
Rouhani, Gazelle
Chevrier, Amy
Ose, Jennifer
Shibata, David
Toriola, Adetunji T.
Figueiredo, Jane C.
Peoples, Anita R.
Li, Christopher I.
Hardikar, Sheetal
Siegel, Erin M.
Gigic, Biljana
Schneider, Martin
Ulrich, Cornelia M.
Kirchhoff, Anne C.
Article History
Received: 3 March 2023
Accepted: 10 March 2023
First Online: 23 March 2023
Declarations
:
: Each site (Cedars-Sinai Medical Center (Los Angeles, California), the University of Health Sciences of Tennessee (Memphis, Tennessee), Fred Hutchinson Cancer Research Center (Seattle, Washington), H. Lee Moffitt Cancer Center Research Institute (Tampa, Florida), Huntsman Cancer Institute (Salt Lake City, Utah), and Washington University School of Medicine (St. Louis, Missouri) received approval from their respected institutional review boards.
: Informed consent was obtained from all individual participants included in the study.
: All research participant data have been de-identified so participants did not need to consent for publication.
: Dr. Cornelia M. Ulrich, as Cancer Center Director, oversees research funded by several pharmaceutical companies but has not received funding directly. The other authors have no conflicts of interest to report.